We are live on ! Find out more
MMRF

Michelson Medical Research Foundation Portfolio holdings

AUM $108M
1-Year Est. Return 29.95%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+29.95%
3 Year Est. Return
+52.22%
5 Year Est. Return
10 Year Est. Return
AUM
$154M
AUM Growth
Cap. Flow
+$155M
Cap. Flow %
100.53%
Top 10 Hldgs %
76.4%
Holding
31
New
31
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Real Estate 12.21%
2 Energy 8.61%
3 Financials 2.32%
4 Industrials 0.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPCA
26
DELISTED
Warburg Pincus Capital Corporation I-A
WPCA
$514K 0.33%
+50,905
New +$509K
WPCB
27
DELISTED
Warburg Pincus Capital Corporation I-B
WPCB
$514K 0.33%
+50,922
New +$510K
LDHA
28
DELISTED
LDH Growth Corp I Class A Ordinary Shares
LDHA
$512K 0.33%
+50,826
New +$508K
ORIA
29
DELISTED
Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA
$510K 0.33%
+50,780
New +$506K
ANAC
30
DELISTED
Arctos NorthStar Acquisition Corp.
ANAC
$500K 0.32%
+49,601
New +$496K
RSX
31
DELISTED
VanEck Russia ETF
RSX
$103K 0.07%
+105,000
New +$593K

Similar funds

Michelson Medical Research Foundation's Q4 2022 Portfolio in Review

Q4 2022 is the first quarter with a 13F filing on record for Michelson Medical Research Foundation, which disclosed 31 positions worth $154M. Its ten largest holdings account for 76% of the portfolio.

Its largest position is iShares iBoxx $ High Yield Corporate Bond ETF: 255,130 shares worth $18.8M.

By sector, the portfolio is most concentrated in Real Estate at 12% of assets, followed by Energy and Financials.

  • Michelson Medical Research Foundation's largest Q4 2022 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 255,130 shares worth $18.8M.
  • Michelson Medical Research Foundation's ten largest holdings make up 76% of its $154M portfolio in Q4 2022.
  • Michelson Medical Research Foundation disclosed 31 positions in Q4 2022, its first 13F filing on record.

Based on Michelson Medical Research Foundation's 13F filing for Q4 2022, filed 13 Feb 2023.